Omega Funds logo

Omega Funds

Europe, Geneve, Switzerland, Geneva

Description

Omega Funds global life sciences-based investment firm that specializes in direct secondary transactions.

Investor Profile

Omega Funds has made 148 investments, with 15 in the past 12 months and 22% as lead.

Stage Focus

  • Series A (25%)
  • Series B (24%)
  • Series Unknown (18%)
  • Series C (16%)
  • Post Ipo Equity (7%)
  • Series D (3%)
  • Seed (3%)
  • Private Equity (1%)
  • Series E (1%)
  • Post Ipo Debt (1%)

Country Focus

  • United States (76%)
  • Switzerland (6%)
  • United Kingdom (3%)
  • France (3%)
  • Germany (3%)
  • Belgium (3%)
  • Canada (1%)
  • Israel (1%)
  • Spain (1%)
  • Denmark (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Health Diagnostics
  • Medical Device
  • Biopharma
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Omega Funds frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 13
OrbiMed
North America, New York, United States, New York
Co-Investments: 19
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 13
CA
North America, Massachusetts, United States, Boston
Co-Investments: 13
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 12
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 18
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 15
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 12
Invus
North America, New York, United States, New York
Co-Investments: 12
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 12

Which angels does Omega Funds often collaborate with?

KC
North America, United States
Shared Deals: 1
David Pyott
North America, California, United States, Orange
Shared Deals: 1
PF
North America, Florida, United States, Miami
Shared Deals: 1
HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1
AB
North America, California, United States, Los Angeles
Shared Deals: 1
TA
North America, Massachusetts, United States, Cambridge
Shared Deals: 2
BN
North America, Massachusetts, United States, Boston
Shared Deals: 1
NB
North America, California, United States, San Mateo
Shared Deals: 2
Shared Deals: 1

What are some of recent deals done by Omega Funds?

Callio Therapeutics

Seattle, Washington, United States

Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).

BiotechnologyHealth CareMedical
Series AMar 3, 2025
Amount Raised: $187,000,000
Alleviant Medical

Austin, Texas, United States

Alleviant Medical develops transcatheter technology designed to lift the clinical and economic burden of heart failure.

BiotechnologyClinical TrialsHealth CareMedical Device
Series UnknownJan 14, 2025
Amount Raised: $90,000,000
Windward Bio

Basel, Basel-Stadt, Switzerland

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

BiotechnologyLife ScienceMedical
Series AJan 10, 2025
Amount Raised: $200,000,000
Aviceda Therapeutics

Cambridge, Massachusetts, United States

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series CJan 7, 2025
Amount Raised: $207,500,000
Ikena Oncology

Boston, Massachusetts, United States

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics
Post Ipo EquityDec 23, 2024
Amount Raised: $75,000,000
nChroma Bio

Boston, Massachusetts, United States

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

BiotechnologyMedicalProduct Research
Series UnknownDec 11, 2024
Amount Raised: $75,000,000
Beta Bionics

Irvine, California, United States

Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.

BiotechnologyDiabetesMedical Device
Series ENov 13, 2024
Amount Raised: $60,000,000
XII Medical

Union City, California, United States

XII Medical provides minimally invasive technology for obstructive sleep apnea.

Health CareMedical DeviceWellness
Series BAug 21, 2024
Amount Raised: $45,000,000
Kestra Medical Technologies, Inc.

Kirkland, Washington, United States

Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.

Health CareHealth DiagnosticsMedical Device
Private EquityJul 24, 2024
Amount Raised: $196,000,000
Third Arc Bio

Boston, Massachusetts, United States

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

BiotechnologyHealth CareLife ScienceMedicalOncology
Series AJul 23, 2024
Amount Raised: $165,000,000